标题
Angiogenesis in Neuroendocrine Tumors: Therapeutic Applications
作者
关键词
-
出版物
NEUROENDOCRINOLOGY
Volume 97, Issue 1, Pages 45-56
出版商
S. Karger AG
发表日期
2012-04-24
DOI
10.1159/000338371
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting the PI3K/mTOR Pathway in Murine Endocrine Cell Lines
- (2011) Christophe Couderc et al. AMERICAN JOURNAL OF PATHOLOGY
- Perfusion CT Findings in Patients With Metastatic Carcinoid Tumors Undergoing Bevacizumab and Interferon Therapy
- (2011) Chaan S. Ng et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors
- (2011) Eric Raymond et al. CANCER AND METASTASIS REVIEWS
- Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape
- (2011) E. di Tomaso et al. CANCER RESEARCH
- Cancer Stem Cells Switch on Tumor Neovascularization
- (2011) Y.-F. Ping et al. CURRENT MOLECULAR MEDICINE
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of Somatostatin and Octreotide on the Interactions between Neoplastic Gastroenteropancreatic Endocrine Cells and Endothelial Cells: A Comparison between in vitro and in vivo Properties
- (2011) Thomas Walter et al. NEUROENDOCRINOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concise Review: Contribution of Cancer Stem Cells to Neovascularization
- (2011) Yi-Fang Ping et al. STEM CELLS
- Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors
- (2011) Catherine Delbaldo et al. Targeted Oncology
- Clinical activity of mammalian target of rapamycin inhibitors in solid tumors
- (2011) Yesid Alvarado et al. Targeted Oncology
- Contribution of cancer stem cells to tumor vasculogenic mimicry
- (2011) Xiao-hong Yao et al. Protein & Cell
- A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors
- (2010) Matthew H. Kulke et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors
- (2010) K. M. Detjen et al. CLINICAL CANCER RESEARCH
- Hypoxia stimulates CXCR4 signalling in ileal carcinoids
- (2010) Yvonne Arvidsson et al. ENDOCRINE-RELATED CANCER
- The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors
- (2010) Nicté Figueroa-Vega et al. ENDOCRINE-RELATED CANCER
- Mechanisms of resistance to antiangiogenesis therapy
- (2010) Faisal Azam et al. EUROPEAN JOURNAL OF CANCER
- Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab
- (2010) Vincenzo Formica et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma
- (2010) Daniel P. Lindholm et al. MEDICAL ONCOLOGY
- Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes
- (2010) F. ROTONDO et al. NEOPLASMA
- VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway
- (2010) Karine Villaume et al. NEUROENDOCRINOLOGY
- Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors
- (2010) Susan A. J. Vaziri et al. Current Oncology Reports
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
- (2009) Kristy J. Gotink et al. ANGIOGENESIS
- Pharmacogenetics in chemotherapy of colorectal cancer
- (2009) Lieke Henriette Tanja et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor
- (2009) Jerry Y. Hsu et al. BIODRUGS
- Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
- (2009) N Murukesh et al. BRITISH JOURNAL OF CANCER
- Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
- (2009) Sonja Loges et al. CANCER CELL
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
- (2009) Annamaria Rapisarda et al. DRUG RESISTANCE UPDATES
- Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis
- (2009) R Srirajaskanthan et al. ENDOCRINE-RELATED CANCER
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- An overview of small-molecule inhibitors of VEGFR signaling
- (2009) S. Percy Ivy et al. Nature Reviews Clinical Oncology
- Vascular Endothelial Growth Factors, Angiogenesis, and Survival in Human Ileal Enterochromaffin Cell Carcinoids
- (2009) Sophie Besig et al. NEUROENDOCRINOLOGY
- Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies
- (2009) Yongping Crawford et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Non-invasive assessment of tumor neovasculature: techniques and clinical applications
- (2008) Rodolfo Perini et al. CANCER AND METASTASIS REVIEWS
- Clinical biomarkers of angiogenesis inhibition
- (2008) Aaron P. Brown et al. CANCER AND METASTASIS REVIEWS
- Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies
- (2008) Axel Grothey et al. CANCER JOURNAL
- Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors
- (2008) A. Couvelard et al. CLINICAL CANCER RESEARCH
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- Anti-VEGF therapy: the search for clinical biomarkers
- (2008) Raffaele Longo et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model
- (2008) A Scholz et al. GUT
- Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
- (2008) D. G. Nowak et al. JOURNAL OF CELL SCIENCE
- Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
- (2008) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Angiogenesis and Tumor Progression in Neuroendocrine Digestive Tumors
- (2008) Gilles Poncet et al. JOURNAL OF SURGICAL RESEARCH
- Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors
- (2008) Anne Couvelard et al. MODERN PATHOLOGY
- Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors1
- (2008) Gaspard d'Assignies et al. RADIOLOGY
- Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
- (2008) Cristiana Sessa et al. Nature clinical practice. Oncology
- The Role of Angiogenesis in Endocrine Liver Metastases: An Experimental Study
- (2007) Céline Pourreyron et al. JOURNAL OF SURGICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now